Among healthy controls, NAFLD and NASH patients, the expression levels of HSP90β, but not HSP90α, was positively correlated with disease progression (Fig. 2m–o). The gene discussed is HSP90AB1; the disease is metabolic dysfunction-associated steatotic liver disease.